Preparation method of compound amino acid injection

By using Angelica polypeptide enzyme solution to replace antioxidants and performing amino acid encapsulation treatment, allergic reactions and oxidation problems caused by sulfite antioxidants are solved, and a stable and safe compound amino acid injection is prepared, suitable for allergic people and improved The effectiveness of the injection.

CN118986871AInactive Publication Date: 2024-11-22FUZHOU NEPTUNUS FUYAO PHARMA
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
CN202411101182.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-12
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Sulfite antioxidants in existing compound amino acid injections may cause allergic reactions and promote the oxidation of the active amino acid ingredients, affecting the effectiveness and safety of the injection.

Method used

The angelica polypeptide enzyme solution is used to replace the antioxidant, and a stable compound amino acid injection is prepared by encapsulating the amino acid composition and specific process steps (such as filtration and sterilization) to avoid oxidation reactions.

Benefits of technology

The prepared compound amino acid injection has better stability and is suitable for people allergic to sulfite antioxidants, extending the effectiveness of the injection and improving safety.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to the technical field of pharmaceutical preparations, in particular to a preparation method of a compound amino acid injection, which comprises the following steps: adding Chinese angelica polypeptide enzymatic hydrolysate prepared from Chinese angelica polypeptide and neutral protease and activated carbon into water in a nitrogen atmosphere, heating, sequentially adding an amino acid composition and xylitol, and uniformly stirring to obtain the compound amino acid injection. And after cooling, adding an amino acid encapsulation liquid, uniformly stirring, adjusting the pH value, filtering, bottling, vacuumizing, filling nitrogen, sealing, sterilizing and cooling to obtain the compound amino acid injection. The amino acid encapsulation liquid is prepared from chitosan, a calcium chloride solution, sodium alginate, five unstable amino acids and the like. The antioxidant is replaced with the angelica sinensis polypeptide enzymatic hydrolysate while active amino acid is encapsulated, so that the stability of the injection is improved, and the injection is suitable for people allergic to sulfite antioxidants. Therefore, the compound amino acid injection prepared by the invention has a wide application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of pharmaceutical preparations, and in particular to a method for preparing a compound amino acid injection. Background Art

[0002] Amino acids are the basic units that make up proteins. There are 20 kinds of amino acids that make up proteins in organisms. Amino acids are divided into essential amino acids and non-essential amino acids. Essential amino acids cannot be synthesized in the body and must be taken in through food or supplements to meet the body's metabolic needs. Compound amino acid injection is a balanced amino acid supplement made of 18 kinds of amino acids and sorbitol in a certain proportion. It is mainly administered clinically through intravenous infusion, so that patients who cannot absorb nutrients through the intestines or whose nutrients cannot meet their needs can obtain enough amino acids to maintain normal metabolism and physiological functions of the body.

[0003] In order to prevent oxidation of amino acids in injections, manufacturers often add sulfite antioxidants, such as sodium bisulfite and sodium pyrosulfite, to compound amino acid injections. For example, patent document CN104042645B discloses a compound amino acid injection, which is prepared from sodium bisulfite and the following components: tyrosine, methionine, glutamic acid, phenylalanine, threonine, tryptophan, L-selenomethylselenocysteine ​​and water-soluble β-cyclodextrin derivatives.

[0004] However, the sulfite antioxidants contained in the injection may cause allergic reactions clinically and pose a potential threat to human health. In addition, sulfite antioxidants have strong reducing properties and may promote redox reactions of the active ingredients of amino acids, generating a series of degradation impurities, thereby affecting the effectiveness and safety of the compound amino acid injection.

[0005] Therefore, according to the above-mentioned related technologies, it is urgent to develop a preparation method for compound amino acid injection. Summary of the invention

[0006] In view of this, the purpose of the present invention is to propose a method for preparing a compound amino acid injection, so as to provide a compound amino acid injection with high stability and suitable for people who are allergic to sulfite antioxidants.

[0007] Based on the above purpose, the present invention provides a method for preparing a compound amino acid injection.

[0008] A method for preparing a compound amino acid injection comprises the following steps:

[0009] Step S1. Add Angelica polypeptide hydrolysate and activated carbon to water under a nitrogen atmosphere, raise the temperature to 70-75° C., then add the amino acid composition and xylitol in sequence and stir evenly to obtain a prepared solution;

[0010] Step S2. Cool the prepared solution to 35-40°C, then add the amino acid encapsulation solution and stir evenly, then add hydrochloric acid to pH = 5.8-6.0 to obtain a crude injection solution;

[0011] Step S3. The crude injection solution is filtered through filters with pore sizes of 4.5-5.0 μm and 0.20-0.22 μm, respectively, and then injected into a glass bottle, which is then evacuated, filled with nitrogen, plugged and capped, and finally sterilized in a water bath at 105-120° C. for 20-35 min, and cooled to 35-50° C. to obtain a compound amino acid injection solution;

[0012] The amino acid composition is obtained by mixing alanine, arginine hydrochloride, aspartic acid, glutamic acid, glycine, histidine hydrochloride, lysine hydrochloride, phenylalanine, proline, serine, tryptophan, tyrosine and valine;

[0013] The angelica polypeptide enzymatic hydrolysate is prepared from water, angelica polypeptide and neutral protease;

[0014] The amino acid encapsulation liquid is prepared from chitosan, acetic acid solution, calcium chloride solution, sodium alginate, water, leucine, isoleucine, threonine, methionine and cysteine ​​hydrochloride in a mass ratio of 1.92-1.95:102-105:90.27-90.30:3.7-4.0:192-195:3.45-4.15:1.55-1.85:1.80-2.15:1.00-1.15:0.40-0.48.

[0015] Preferably, in step S1, the mass ratio of water, Angelica polypeptide hydrolysate, activated carbon, amino acid composition and xylitol is 340-370:168-171:0.5-1.1:21.21-25.19:45-55.

[0016] Preferably, the mass ratio of alanine, arginine hydrochloride, aspartic acid, glutamic acid, glycine, histidine hydrochloride, lysine hydrochloride, phenylalanine, proline, serine, tryptophan, tyrosine and valine in the amino acid composition is 1.70-2.00: 2.70-3.00: 1.05-1.25: 1.75-2.15: 2.95-3.55: 2.25-2.70: 3.00-3.65: 2.55-3.10: 0.90-1.10: 0.65-0.70: 0.36-0.42: 0.10-0.12: 1.25-1.45.

[0017] Preferably, the mass ratio of the preparation solution to the amino acid encapsulation solution in step S2 is 600-604:398-406.

[0018] Preferably, the preparation method of the Angelica polypeptide enzymatic hydrolysate is as follows:

[0019] Add angelica polypeptide to water, stir evenly, then add neutral protease, perform enzymolysis at 42-45°C for 2.7-3.0 hours, and obtain angelica polypeptide enzymolysis solution.

[0020] Preferably, the mass ratio of water, angelica polypeptide and neutral protease is 167-170:0.7-1.0:0.69-0.72.

[0021] Preferably, the preparation method of the amino acid encapsulation solution is as follows:

[0022] Step A1. Dissolve chitosan in acetic acid solution, stir until chitosan is completely dissolved, and then adjust the pH to 5.7-6.0 with hydrochloric acid to obtain a chitosan composite solution;

[0023] Step A2. Dissolve sodium alginate in water and stir until the sodium alginate is completely dissolved, then add leucine, isoleucine, threonine, methionine, cysteine ​​and cystine, and stir again to obtain a sodium alginate composite solution;

[0024] Step A3. Add the sodium alginate complex solution dropwise into the calcium chloride solution, then add the chitosan encapsulation solution, and stir for 30-40 minutes. During this time, turn on the ultrasonic generator to oscillate once every 10-13 minutes, each time for 1-2 minutes, to obtain the amino acid encapsulation solution.

[0025] Preferably, the concentration of the acetic acid solution in step A1 is 1%-1.5%.

[0026] Preferably, the concentration of the calcium chloride solution in step A3 is 1.7%-2.0%.

[0027] A compound amino acid injection, characterized in that the injection is prepared by the preparation method according to any one of claims 1 to 9.

[0028] Beneficial effects of the present invention:

[0029] The present invention provides a method for preparing a compound amino acid injection. The present invention alleviates the problem that amino acids are easily oxidized and denatured during storage by encapsulating relatively active amino acids and replacing antioxidants with angelica polypeptide enzymatic hydrolysate. Compared with the prior art, the compound amino acid injection prepared by the present invention not only has better stability, but is also suitable for people who are allergic to sulfite antioxidants. Therefore, the compound amino acid injection prepared by the present invention has broad application prospects. DETAILED DESCRIPTION

[0030] In order to make the objectives, technical solutions and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with specific embodiments.

[0031] The sources and properties of some of the raw materials used in the present invention are as follows:

[0032] Example 1: A method for preparing a compound amino acid injection, comprising the following steps:

[0033] Step S1. Add 0.7 g of Angelica polypeptide to 167 g of water, stir evenly, add 0.69 g of neutral protease, and perform enzymolysis at 42° C. for 2.7 h to obtain Angelica polypeptide enzymolysis solution;

[0034] Step S2. 1.70 g alanine, 2.70 g arginine hydrochloride, 1.05 g aspartic acid, 1.75 g glutamic acid, 2.95 g glycine, 2.25 g histidine hydrochloride, 3.00 g lysine hydrochloride, 2.55 g phenylalanine, 0.90 g proline, 0.65 g serine, 0.36 g tryptophan, 0.10 g tyrosine and 1.25 g valine are mixed to obtain an amino acid composition;

[0035] Step S3. Add 168 g of Angelica polypeptide hydrolysate and 0.5 g of activated carbon to 340 g of water under a nitrogen atmosphere, raise the temperature to 70° C., then add 21.21 g of the amino acid composition and 45 g of xylitol in sequence and stir evenly to obtain a prepared solution;

[0036] Step S4. Dissolve 1.92 g of chitosan in 102 g of 1% acetic acid solution, stir until the chitosan is completely dissolved, and then adjust the pH to 5.7 with hydrochloric acid to obtain a chitosan composite solution;

[0037] Step S5. Dissolve 3.7 g of sodium alginate in 192 g of water, stir until the sodium alginate is completely dissolved, then add 3.45 g of leucine, 1.55 g of isoleucine, 1.80 g of threonine, 1.00 g of methionine and 0.40 g of cysteine ​​hydrochloride, stir again to obtain a sodium alginate composite solution;

[0038] Step S6. 203.90 g of sodium alginate composite liquid was added dropwise to 90.27 g of 1.7% calcium chloride solution, and then 103.92 g of chitosan composite liquid was added, and stirred for 30 min, during which the ultrasonic generator was turned on for oscillation once every 10 min, each time for 1 min, to obtain an amino acid encapsulation liquid;

[0039] Step S7. Cool 600 g of the prepared solution to 35° C., then add 398 g of amino acid encapsulation solution and stir evenly, then add hydrochloric acid to pH = 5.8 to obtain a crude injection solution;

[0040] Step S8. The crude injection solution is filtered with filters having a pore size of 4.5-5.0 μm and 0.20-0.22 μm in turn, and then injected into a glass bottle, and then vacuumed, filled with nitrogen, plugged and capped, and finally sterilized in a water bath at 105°C for 20 min, and cooled to 35°C to obtain a compound amino acid injection solution;

[0041] Example 2: A method for preparing a compound amino acid injection, comprising the following steps:

[0042] Step S1. Add 0.8 g of Angelica polypeptide to 168 g of water, stir evenly, add 0.70 g of neutral protease, and perform enzymolysis at 43° C. for 2.8 h to obtain Angelica polypeptide enzymolysis solution;

[0043] Step S2. 1.80 g alanine, 2.80 g arginine hydrochloride, 1.10 g aspartic acid, 1.85 g glutamic acid, 3.15 g glycine, 2.40 g histidine hydrochloride, 3.20 g lysine hydrochloride, 2.70 g phenylalanine, 0.93 g proline, 0.67 g serine, 0.38 g tryptophan, 0.11 g tyrosine and 1.30 g valine are mixed to obtain an amino acid composition;

[0044] Step S3. Add 169 g of Angelica polypeptide hydrolysate and 0.7 g of activated carbon to 350 g of water under a nitrogen atmosphere, raise the temperature to 72 ° C, then add 22.21 g of the amino acid composition and 48 g of xylitol in sequence and stir evenly to obtain a prepared solution;

[0045] Step S4. Dissolve 1.93 g of chitosan in 103 g of 1.1% acetic acid solution, stir until the chitosan is completely dissolved, and then adjust the pH to 5.8 with hydrochloric acid to obtain a chitosan composite solution;

[0046] Step S5. Dissolve 3.8 g of sodium alginate in 193 g of water, stir until the sodium alginate is completely dissolved, then add 3.65 g of leucine, 1.65 g of isoleucine, 1.90 g of threonine, 1.05 g of methionine and 0.42 g of cysteine ​​hydrochloride, stir again to obtain a sodium alginate composite solution;

[0047] Step S6. 205.9 g of sodium alginate composite liquid was added dropwise to 90.28 g of 1.8% calcium chloride solution, and then 104.92 g of chitosan composite liquid was added, and stirred for 33 min, during which the ultrasonic generator was turned on for 1 min every 11 min to obtain an amino acid encapsulation liquid;

[0048] Step S7. Cool 601 g of the prepared solution to 36° C., then add 400 g of the amino acid encapsulation solution and stir evenly, then add hydrochloric acid to pH = 5.8 to obtain a crude injection solution;

[0049] Step S8. The crude injection solution is filtered through filters with pore sizes of 4.5-5.0 μm and 0.20-0.22 μm in turn, and then injected into a glass bottle, which is then evacuated, filled with nitrogen, plugged and capped, and finally sterilized in a water bath at 110° C. for 25 min, and cooled to 40° C. to obtain a compound amino acid injection solution;

[0050] Example 3: A method for preparing a compound amino acid injection, comprising the following steps:

[0051] Step S1. Add 0.9 g of Angelica polypeptide to 169 g of water, stir evenly, add 0.71 g of neutral protease, and perform enzymolysis at 44° C. for 2.9 h to obtain Angelica polypeptide enzymolysis solution;

[0052] Step S2. 1.90 g alanine, 2.90 g arginine hydrochloride, 1.20 g aspartic acid, 2.00 g glutamic acid, 3.35 g glycine, 2.55 g histidine hydrochloride, 3.45 g lysine hydrochloride, 2.95 g phenylalanine, 0.98 g proline, 0.68 g serine, 0.40 g tryptophan, 0.11 g tyrosine and 1.35 g valine are mixed to obtain an amino acid composition;

[0053] Step S3. Add 170 g of Angelica polypeptide hydrolysate and 0.9 g of activated carbon to 360 g of water under a nitrogen atmosphere, raise the temperature to 74 ° C, then add 24.21 g of the amino acid composition and 52 g of xylitol in sequence and stir evenly to obtain a prepared solution;

[0054] Step S4. Dissolve 1.94 g of chitosan in 104 g of 1.4% acetic acid solution, stir until the chitosan is completely dissolved, and then adjust the pH to 5.9 with hydrochloric acid to obtain a chitosan composite solution;

[0055] Step S5. 3.9 g of sodium alginate was dissolved in 194 g of water, and the mixture was stirred until the sodium alginate was completely dissolved. Then, 4.00 g of leucine, 1.75 g of isoleucine, 2.05 g of threonine, 1.05 g of methionine and 0.46 g of cysteine ​​hydrochloride were added, and the mixture was stirred again to obtain a sodium alginate composite solution.

[0056] Step S6. 207.78 g of sodium alginate composite liquid was added dropwise to 90.29 g of 1.9% calcium chloride solution, and then 105.95 g of chitosan composite liquid was added, and stirred for 37 min, during which the ultrasonic generator was turned on for oscillation once every 12 min, each time for 2 min, to obtain an amino acid encapsulation liquid;

[0057] Step S7. Cool 603 g of the prepared solution to 40° C., then add 403 g of the amino acid encapsulation solution and stir evenly, then add hydrochloric acid to pH = 5.9 to obtain a crude injection solution;

[0058] Step S8. The crude injection solution is filtered through filters with pore sizes of 4.5-5.0 μm and 0.20-0.22 μm in turn, and then injected into a glass bottle, which is then evacuated, filled with nitrogen, plugged and capped, and finally sterilized in a water bath at 115° C. for 30 min, and cooled to 45° C. to obtain a compound amino acid injection solution;

[0059] Example 4: A method for preparing a compound amino acid injection, comprising the following steps:

[0060] Step S1. Add 1.0 g of Angelica polypeptide to 170 g of water, stir evenly, add 0.72 g of neutral protease, and perform enzymolysis at 45° C. for 3 h to obtain Angelica polypeptide enzymolysis solution;

[0061] Step S2. 2.00 g of alanine, 3.00 g of arginine hydrochloride, 1.25 g of aspartic acid, 2.15 g of glutamic acid, 3.55 g of glycine, 2.70 g of histidine hydrochloride, 3.65 g of lysine hydrochloride, 3.10 g of phenylalanine, 1.10 g of proline, 0.70 g of serine, 0.42 g of tryptophan, 0.12 g of tyrosine and 1.45 g of valine were mixed to obtain an amino acid composition;

[0062] Step S3. Add 171 g of Angelica polypeptide hydrolysate and 1.1 g of activated carbon to 370 g of water under a nitrogen atmosphere, raise the temperature to 75° C., then add 25.19 g of the amino acid composition and 55 g of xylitol in sequence and stir evenly to obtain a prepared solution;

[0063] Step S4. Dissolve 1.95 g of chitosan in 105 g of 1.5% acetic acid solution, stir until the chitosan is completely dissolved, and then adjust the pH to 6.0 with hydrochloric acid to obtain a chitosan composite solution;

[0064] Step S5. Dissolve 4.0 g of sodium alginate in 195 g of water, stir until the sodium alginate is completely dissolved, then add 4.15 g of leucine, 1.85 g of isoleucine, 2.15 g of threonine, 1.15 g of methionine and 0.48 g of cysteine ​​hydrochloride, stir again to obtain a sodium alginate composite solution;

[0065] Step S6. 208.78 g of sodium alginate composite liquid was added dropwise to 90.30 g of 2.0% calcium chloride solution, and then 106.95 g of chitosan composite liquid was added, and stirred for 40 min, during which the ultrasonic generator was turned on for oscillation once every 13 min, each time for 2 min, to obtain an amino acid encapsulation liquid;

[0066] Step S7. Cool 604 g of the prepared solution to 40° C., then add 406 g of the amino acid encapsulation solution and stir evenly, then add hydrochloric acid to pH = 6.0 to obtain a crude injection solution;

[0067] Step S8. The crude injection solution is filtered with filters having a pore size of 4.5-5.0 μm and 0.20-0.22 μm in turn, and then injected into a glass bottle, and then vacuumed, filled with nitrogen, plugged and capped, and finally sterilized in a water bath at 120° C. for 35 min, and cooled to 50° C. to obtain a compound amino acid injection solution;

[0068] Comparative Example 1: A method for preparing a compound amino acid injection, comprising the following steps:

[0069] Step S1. Add 0.3 g of sodium bisulfite to 167.7 g of water and stir to obtain an antioxidant solution;

[0070] Step S2. 1.70 g alanine, 2.70 g arginine hydrochloride, 1.05 g aspartic acid, 1.75 g glutamic acid, 2.95 g glycine, 2.25 g histidine hydrochloride, 3.00 g lysine hydrochloride, 2.55 g phenylalanine, 0.90 g proline, 0.65 g serine, 0.36 g tryptophan, 0.10 g tyrosine and 1.25 g valine are mixed to obtain an amino acid composition;

[0071] Step S3. Add 168 g of antioxidant solution and 0.5 g of activated carbon to 340 g of water under a nitrogen atmosphere, raise the temperature to 70° C., then add 21.21 g of the amino acid composition and 45 g of xylitol in sequence and stir evenly to obtain a prepared solution;

[0072] Step S4. Dissolve 1.92 g of chitosan in 102 g of 1% acetic acid solution, stir until the chitosan is completely dissolved, and then adjust the pH to 5.7 with hydrochloric acid to obtain a chitosan composite solution;

[0073] Step S5. Dissolve 3.7 g of sodium alginate in 192 g of water, stir until the sodium alginate is completely dissolved, then add 3.45 g of leucine, 1.55 g of isoleucine, 1.80 g of threonine, 1.00 g of methionine and 0.40 g of cysteine ​​hydrochloride, stir again to obtain a sodium alginate composite solution;

[0074] Step S6. 203.90 g of sodium alginate composite liquid was added dropwise to 90.27 g of 1.7% calcium chloride solution, and then 103.92 g of chitosan composite liquid was added, and stirred for 30 min, during which the ultrasonic generator was turned on for oscillation once every 10 min, each time for 1 min, to obtain an amino acid encapsulation liquid;

[0075] Step S7. Cool 600 g of the prepared solution to 35° C., then add 398 g of amino acid encapsulation solution and stir evenly, then add hydrochloric acid to pH = 5.8 to obtain a crude injection solution;

[0076] Step S8. The crude injection solution is filtered with filters having a pore size of 4.5-5.0 μm and 0.20-0.22 μm in turn, and then injected into a glass bottle, and then vacuumed, filled with nitrogen, plugged and capped, and finally sterilized in a water bath at 105°C for 20 min, and cooled to 35°C to obtain a compound amino acid injection solution;

[0077] Comparative Example 2: A method for preparing a compound amino acid injection, comprising the following steps:

[0078] Step S1. Add 0.7 g of Angelica polypeptide to 167 g of water, stir evenly, add 0.69 g of neutral protease, and perform enzymolysis at 42° C. for 2.7 h to obtain Angelica polypeptide enzymolysis solution;

[0079] Step S2. 1.70 g alanine, 2.70 g arginine hydrochloride, 1.05 g aspartic acid, 1.75 g glutamic acid, 2.95 g glycine, 2.25 g histidine hydrochloride, 3.00 g lysine hydrochloride, 2.55 g phenylalanine, 0.90 g proline, 0.65 g serine, 0.36 g tryptophan, 0.10 g tyrosine and 1.25 g valine are mixed to obtain an amino acid composition;

[0080] Step S3. Add 168 g of Angelica polypeptide hydrolysate and 0.5 g of activated carbon to 340 g of water under a nitrogen atmosphere, raise the temperature to 70° C., then add 21.21 g of the amino acid composition and 45 g of xylitol in sequence and stir evenly to obtain a prepared solution;

[0081] Step S4. Add 3.45 g of leucine, 1.55 g of isoleucine, 1.80 g of threonine, 1.00 g of methionine and 0.40 g of cysteine ​​hydrochloride to 389.8 g of water and stir to obtain an amino acid mixture;

[0082] Step S5. Cool 600 g of the prepared solution to 35°C, then add 398 g of the amino acid mixture and stir evenly, then add hydrochloric acid to pH = 5.8 to obtain a crude injection solution;

[0083] Step S6. The crude injection solution is filtered with filters with pore sizes of 4.5-5.0 μm and 0.20-0.22 μm in turn, and then injected into a glass bottle, and then vacuumed, filled with nitrogen, plugged and capped, and finally sterilized in a water bath at 105°C for 20 min, and cooled to 35°C to obtain a compound amino acid injection solution;

[0084] Comparative Example 3: A method for preparing a compound amino acid injection, comprising the following steps:

[0085] Step S1. Add 0.3 g of sodium bisulfite to 167.7 g of water and stir to obtain an antioxidant solution;

[0086] Step S2. 1.70 g alanine, 2.70 g arginine hydrochloride, 1.05 g aspartic acid, 1.75 g glutamic acid, 2.95 g glycine, 2.25 g histidine hydrochloride, 3.00 g lysine hydrochloride, 2.55 g phenylalanine, 0.90 g proline, 0.65 g serine, 0.36 g tryptophan, 0.10 g tyrosine and 1.25 g valine are mixed to obtain an amino acid composition;

[0087] Step S3. Add 168 g of antioxidant solution and 0.5 g of activated carbon to 340 g of water under a nitrogen atmosphere, raise the temperature to 70° C., then add 21.21 g of the amino acid composition and 45 g of xylitol in sequence and stir evenly to obtain a prepared solution;

[0088] Step S4. Add 3.45 g of leucine, 1.55 g of isoleucine, 1.80 g of threonine, 1.00 g of methionine and 0.40 g of cysteine ​​hydrochloride to 389.8 g of water and stir to obtain an amino acid mixture;

[0089] Step S5. Cool 600 g of the prepared solution to 35°C, then add 398 g of the amino acid mixture and stir evenly, then add hydrochloric acid to pH = 5.8 to obtain a crude injection solution;

[0090] Step S6. The crude injection solution is filtered with filters with pore sizes of 4.5-5.0 μm and 0.20-0.22 μm in turn, and then injected into a glass bottle, which is then evacuated, filled with nitrogen, plugged and capped, and finally sterilized in a water bath at 105° C. for 20 min, and cooled to 35° C. to obtain a compound amino acid injection solution.

[0091] Performance Testing:

[0092] The performance tests were performed on the compound amino acid injections prepared in Examples 1 to 4 and Comparative Examples 1 to 3:

[0093] pH test:

[0094] Referring to the general rule 0631 "pH determination method" in Part 4 of the 2020 edition of the Chinese Pharmacopoeia, the pH value of the compound amino acid injection prepared in Example 1 to Example 4 and Comparative Example 1 to Comparative Example 3 was measured using a pH meter (PHS-3C, Shanghai Precision Scientific Instrument Co., Ltd.);

[0095] Light transmittance test:

[0096] Referring to the test standard of General Rule 0401 "Ultraviolet-visible spectrophotometry" in Part 4 of the 2020 edition of the Chinese Pharmacopoeia, an ultraviolet-visible spectrophotometer (UV-1780, Shimadzu Corporation, Japan) was used to measure the transmittance (%) of the compound amino acid injection prepared in Example 1 to Example 4 and Comparative Example 1 to Comparative Example 3 at a wavelength of 430 nm;

[0097] Test of light transmittance after 1 year:

[0098] Referring to the test standard of General Rule 0401 "Ultraviolet Visible Spectrophotometry" in Part 4 of the 2020 edition of the Chinese Pharmacopoeia, the transmittance (%) of the compound amino acid injection prepared in Example 1 to Example 4 and Comparative Example 1 to Comparative Example 3 at a wavelength of 430 nm after storage for one year was tested using an ultraviolet visible spectrophotometer (UV-1780, Shimadzu Corporation, Japan);

[0099] Heavy metal content test:

[0100] Referring to the test standard of General Rule 0821 "Heavy Metal Inspection Method" in Part IV of the 2020 edition of the Chinese Pharmacopoeia, 20 mL of the compound amino acid injection prepared in Example 1-Example 4 and Comparative Example 1-Comparative Example 3 were taken, and the heavy metal content (%) was tested after evaporation in a water bath. The heavy metal content shall not exceed 2% of the xylitol content; the test results are shown in Table 1:

[0101] Table 1

[0102] project pH Light transmittance / % Light transmittance after 1 year / % Heavy metal content / % Example 1 5.8 99.4 99.0 0.03 Example 2 5.8 99.1 98.9 0.02 Example 3 5.9 99.8 99.4 0.02 Example 4 6.0 99.6 99.3 0.03 Comparative Example 1 5.8 98.5 97.6 0.04 Comparative Example 2 5.8 98.6 97.6 0.04 Comparative Example 3 5.8 98.2 97.0 0.05

[0103] Data Analysis:

[0104] As can be seen from Table 1, the compound amino acid injection prepared by the present invention has a higher transmittance, and the transmittance change after one year of storage is relatively small, and the pH value and heavy metal content are in line with national standards;

[0105] This may be because the present invention effectively alleviates the problem of amino acids being easily oxidized and denatured during storage by encapsulating more active amino acids and replacing antioxidants with angelica polypeptide enzymatic hydrolysate. Therefore, the compound amino acid injection prepared by the present invention has better stability, so its transmittance is relatively high, and the transmittance change is relatively small after one year of storage.

[0106] In Comparative Example 1, no Angelica polypeptide hydrolysate was prepared and added, and it was replaced with an antioxidant solution prepared with sodium bisulfite. It can be seen from Table 1 that compared with Example 1, its transmittance is lower and the transmittance after one year of storage is reduced more. This may be because compared with the Angelica polypeptide hydrolysate, the antioxidant solution prepared with sodium bisulfite has a stronger reducing ability, which will cause other components in the compound amino acid injection to be reduced and precipitate, resulting in a decrease in transmittance. Comparative Example 2 did not encapsulate the more active amino acids. It can be seen from Table 1 that compared with Example 1, its transmittance is lower and the transmittance after one year of storage is reduced. The light transmittance is reduced more; this may be because the encapsulation treatment can prevent the relatively active amino acids from contacting with water or active substances in other components, thereby further reducing the possibility of their denaturation; Comparative Example 3, that is, no Angelica polypeptide enzymatic hydrolysate was prepared and added, and it was replaced with an antioxidant solution prepared by sodium bisulfite, and the relatively active amino acids were not encapsulated. It can be seen from Table 1 that its light transmittance is the lowest and the light transmittance after one year of storage is reduced the most. This may be because the addition of Angelica polypeptide enzymatic hydrolysate on the basis of encapsulation treatment can further improve the stability of the compound amino acid injection.

[0107] Those skilled in the art should understand that the discussion of any of the above embodiments is merely illustrative and is not intended to imply that the scope of the present invention is limited to these examples. Under the concept of the present invention, the technical features in the above embodiments or different embodiments may be combined, the steps may be implemented in any order, and there are many other variations of the different aspects of the present invention as described above, which are not provided in detail for the sake of simplicity.

[0108] The present invention is intended to cover all such substitutions, modifications and variations that fall within the broad scope of the appended claims. Therefore, any omissions, modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the scope of protection of the present invention.

Claims

1. A method for preparing a compound amino acid injection, characterized in that: The specific steps include: Step S1. Add Angelica polypeptide hydrolysate and activated carbon to water under a nitrogen atmosphere, raise the temperature to 70-75° C., then add the amino acid composition and xylitol in sequence and stir evenly to obtain a prepared solution; Step S2. Cool the prepared solution to 35-40°C, then add the amino acid encapsulation solution and stir evenly, then add hydrochloric acid to pH = 5.8-6.0 to obtain a crude injection solution; Step S3. The crude injection solution is filtered through filters with pore sizes of 4.5-5.0 μm and 0.20-0.22 μm, respectively, and then injected into a glass bottle, which is then evacuated, filled with nitrogen, plugged and capped, and finally sterilized in a water bath at 105-120° C. for 20-35 min, and cooled to 35-50° C. to obtain a compound amino acid injection solution; The amino acid composition is obtained by mixing alanine, arginine hydrochloride, aspartic acid, glutamic acid, glycine, histidine hydrochloride, lysine hydrochloride, phenylalanine, proline, serine, tryptophan, tyrosine and valine; The angelica polypeptide enzymatic hydrolysate is prepared from water, angelica polypeptide and neutral protease; The amino acid encapsulation liquid is prepared from chitosan, acetic acid solution, calcium chloride solution, sodium alginate, water, leucine, isoleucine, threonine, methionine and cysteine ​​hydrochloride in a mass ratio of 1.92-1.95:102-105:90.27-90.30:3.7-4.0:192-195:3.45-4.15:1.55-1.85:1.80-2.15:1.00-1.15:0.40-0.

48.

2. The method for preparing the compound amino acid injection according to claim 1, characterized in that: The mass ratio of water, angelica polypeptide hydrolyzate, activated carbon, amino acid composition and xylitol in step S1 is 340-370:168-171:0.5-1.1:21.21-25.19:45-55.

3. The method for preparing the compound amino acid injection according to claim 1, characterized in that: The mass ratios of alanine, arginine hydrochloride, aspartic acid, glutamic acid, glycine, histidine hydrochloride, lysine hydrochloride, phenylalanine, proline, serine, tryptophan, tyrosine and valine in the amino acid composition are 1.70-2.00: 2.70-3.00: 1.05-1.25: 1.75-2.15: 2.95-3.55: 2.25-2.70: 3.00-3.65: 2.55-3.10: 0.90-1.10: 0.65-0.70: 0.36-0.42: 0.10-0.12: 1.25-1.

45.

4. The method for preparing the compound amino acid injection according to claim 1, characterized in that: The mass ratio of the preparation solution and the amino acid encapsulation solution in step S2 is 600-604:398-406.

5. The method for preparing the compound amino acid injection according to claim 1, characterized in that: The preparation method of the Angelica polypeptide enzymatic hydrolysate is as follows: Add angelica polypeptide to water, stir evenly, then add neutral protease, perform enzymolysis at 42-45°C for 2.7-3.0 hours, and obtain angelica polypeptide enzymolysis solution.

6. The method for preparing the compound amino acid injection according to claim 5, characterized in that: The mass ratio of water, angelica polypeptide and neutral protease is 167-170:0.7-1.0:0.69-0.

72.

7. The method for preparing the compound amino acid injection according to claim 1, characterized in that: The preparation method of the amino acid encapsulation solution is as follows: Step A1. Dissolve chitosan in acetic acid solution, stir until chitosan is completely dissolved, and then adjust the pH to 5.7-6.0 with hydrochloric acid to obtain a chitosan composite solution; Step A2. Dissolve sodium alginate in water and stir until the sodium alginate is completely dissolved, then add leucine, isoleucine, threonine, methionine, cysteine ​​and cystine, and stir again to obtain a sodium alginate composite solution; Step A3. Add the sodium alginate complex solution dropwise into the calcium chloride solution, then add the chitosan complex solution, and stir for 30-40 minutes. During this time, turn on the ultrasonic generator to oscillate once every 10-13 minutes, each time for 1-2 minutes, to obtain the amino acid encapsulation solution.

8. The method for preparing the compound amino acid injection according to claim 7, characterized in that: The concentration of the acetic acid solution in step A1 is 1%-1.5%.

9. The method for preparing the compound amino acid injection according to claim 7, characterized in that: The concentration of the calcium chloride solution in step A3 is 1.7%-2.0%.

10. A compound amino acid injection, characterized in that: The injection is prepared by the preparation method according to any one of claims 1 to 9.

Citation Information

Patent Citations

  • Pharmaceutical composition containing 18 kinds of amino acids

    CN103315998A

  • Compound 18-amino acid injection containing little amount of antioxidant and preparation method thereof

    CN103340853A

  • Compound amino acid injection and preparation technology process thereof

    CN103948588A

  • Compound amino acid injection

    CN104042645A

  • Application of Chinese angelica polypeptide with effects of resisting oxidization and delaying ageing in preparation of food

    CN104522683A